334 related articles for article (PubMed ID: 22281192)
1. Lacosamide treatment of juvenile myoclonic epilepsy.
Afra P; Adamolekun B
Seizure; 2012 Apr; 21(3):202-4. PubMed ID: 22281192
[TBL] [Abstract][Full Text] [Related]
2. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
[TBL] [Abstract][Full Text] [Related]
3. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
Montouris G; Abou-Khalil B
Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
[TBL] [Abstract][Full Text] [Related]
4. Effects of zonisamide on the electroencephalogram of a patient with juvenile myoclonic epilepsy.
Szaflarski JP
Epilepsy Behav; 2004 Dec; 5(6):1024-6. PubMed ID: 15582856
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy.
Yorns WR; Khurana DS; Carvalho KS; Hardison HH; Legido A; Valencia I
J Child Neurol; 2014 Jan; 29(1):23-7. PubMed ID: 23143718
[TBL] [Abstract][Full Text] [Related]
6. Two-year efficacy of lacosamide as adjunctive therapy for generalized tonic-clonic seizures in patients with juvenile myoclonic epilepsy.
Kobayashi Y; Honda R; Yamada K; Hojo M; Miura M; Seki E; Ono T; Tohyama J
Brain Dev; 2023 Sep; 45(8):451-455. PubMed ID: 37308336
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
[TBL] [Abstract][Full Text] [Related]
8. Topiramate in patients with juvenile myoclonic epilepsy.
Biton V; Bourgeois BF;
Arch Neurol; 2005 Nov; 62(11):1705-8. PubMed ID: 16286543
[TBL] [Abstract][Full Text] [Related]
9. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies.
Gelisse P; Genton P; Kuate C; Pesenti A; Baldy-Moulinier M; Crespel A
Epilepsia; 2004 Oct; 45(10):1282-6. PubMed ID: 15461683
[TBL] [Abstract][Full Text] [Related]
10. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
11. Absence status induced by lacosamide adjunctive therapy.
Ákos Szabó C; Morgan LC; Sonnenberg S; Karkar KM
Epileptic Disord; 2019 Feb; 21(1):97-101. PubMed ID: 30782579
[TBL] [Abstract][Full Text] [Related]
12. Potential efficacy of zonisamide in refractory juvenile myoclonic epilepsy: retrospective evidence from an Irish compassionate-use case series.
O'Rourke D; Flynn C; White M; Doherty C; Delanty N
Ir Med J; 2007 Apr; 100(4):431-3. PubMed ID: 17566478
[TBL] [Abstract][Full Text] [Related]
13. Seizure outcome in 175 patients with juvenile myoclonic epilepsy--a long-term observational study.
Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E
Epilepsy Res; 2014 Dec; 108(10):1817-24. PubMed ID: 25443450
[TBL] [Abstract][Full Text] [Related]
14. The treatment of juvenile myoclonic epilepsy.
Verrotti A; Manco R; di Marco G; Chiarelli F; Franzoni E
Expert Rev Neurother; 2006 Jun; 6(6):847-54. PubMed ID: 16784408
[TBL] [Abstract][Full Text] [Related]
15. [Juvenile myoclonic epilepsy with recurrent myoclonic status: efficacy of valproate].
Crespel A; Velizarova R; Genton P; Gélisse P
Therapie; 2009; 64(5):321-3. PubMed ID: 19863907
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes.
Di Bonaventura C; Fattouch J; Mari F; Egeo G; Vaudano AE; Prencipe M; Manfredi M; Giallonardo AT
Epileptic Disord; 2005 Sep; 7(3):231-5. PubMed ID: 16162433
[TBL] [Abstract][Full Text] [Related]
18. Levetiracetam may worsen myoclonus in patients with juvenile myoclonic epilepsy: case reports.
Babtain FA
Clin Neuropharmacol; 2012; 35(4):201-2. PubMed ID: 22805231
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy.
Sala-Padró J; Toledo M; Santamarina E; González-Cuevas M; Raspall-Chaure M; Sueiras-Gil M; Quintana M; Salas-Puig X
Clin Neuropharmacol; 2016; 39(6):299-301. PubMed ID: 27438183
[TBL] [Abstract][Full Text] [Related]
20. Lacosamide in refractory mixed pediatric epilepsy: a prospective add-on study.
Rastogi RG; Ng YT
J Child Neurol; 2012 Apr; 27(4):492-5. PubMed ID: 22467791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
